$0.40
19.77% yesterday
Nasdaq, Nov 25, 10:13 pm CET
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Molecular Templates, Inc. Stock price

$0.40
-0.20 33.07% 1M
-0.85 67.87% 6M
-3.33 89.23% YTD
-4.80 92.28% 1Y
-64.10 99.38% 3Y
-160.40 99.75% 5Y
-478.10 99.92% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.07 19.77%
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Key metrics

Market capitalization $2.64m
Enterprise Value $4.01m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.16
P/S ratio (TTM) P/S ratio 0.10
P/B ratio (TTM) P/B ratio 0.37
Revenue growth (TTM) Revenue growth -49.41%
Revenue (TTM) Revenue $25.47m
EBIT (operating result TTM) EBIT $-18.85m
Free Cash Flow (TTM) Free Cash Flow $-23.92m
Cash position $9.66m
EPS (TTM) EPS $-2.70
P/E forward negative
P/S forward 0.40
EV/Sales forward 0.51
Short interest 5.85%
Show more

Is Molecular Templates, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Molecular Templates, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Molecular Templates, Inc.:

Buy
100%

Financial data from Molecular Templates, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
25 25
49% 49%
100%
- Direct Costs 5.01 5.01
38% 38%
20%
20 20
52% 52%
80%
- Selling and Administrative Expenses 5.08 5.08
25% 25%
20%
- Research and Development Expense 29 29
59% 59%
115%
-14 -14
62% 62%
-54%
- Depreciation and Amortization 5.01 5.01
38% 38%
20%
EBIT (Operating Income) EBIT -19 -19
58% 58%
-74%
Net Profit -16 -16
67% 67%
-61%

In millions USD.

Don't miss a Thing! We will send you all news about Molecular Templates, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Molecular Templates, Inc. Stock News

Neutral
GlobeNewsWire
3 months ago
AUSTIN, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results...
Neutral
GlobeNewsWire
6 months ago
AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage company focused on the discovery and development of targeted biologic therapeutics with unique mechanisms of action (engineered toxin bodies or “ETBs”) for cancer and immune-mediated disease, today provided an update on its clinical-stage programs.

Company Profile

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

Head office United States
CEO Eric Poma
Employees 62
Founded 2000
Website www.mtem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today